FMC Brunswick County in Supply, North Carolina - Dialysis Center

FMC Brunswick County is a medicare approved dialysis facility center in Supply, North Carolina and it has 10 dialysis stations. It is located in Brunswick county at 98 Stone Chimney Road Se, Supply, NC, 28462. You can reach out to the office of FMC Brunswick County at (910) 754-3280. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC Brunswick County has the following ownership type - Profit. It was first certified by medicare in August, 2012. The medicare id for this facility is 342689 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameFMC Brunswick County
Location98 Stone Chimney Road Se, Supply, North Carolina
No. of Dialysis Stations 10
Medicare ID342689
Managed ByFresenius Medical Care
Ownership TypeProfit
Late Shifts No

Contact Information


98 Stone Chimney Road Se, Supply, North Carolina, 28462
(910) 754-3280
Not Available

News Archive

First clinical use of GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface on lower profile delivery system

W. L. Gore & Associates (Gore) today reported the first clinical use in the U.S. of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface on a lower profile delivery system. The GORE VIABAHN Device is designed to percutaneously treat Superficial Femoral Artery (SFA) and iliac peripheral artery disease by relining the native vessel.

Research team urges shake-up in mental health provision to enhance patient care

A new study published in the journal Social Theory & Health has called into question how patients interact and respond to psychiatry when they present to mental health services.

Obtained SARS-CoV-2 immunity, naturally or via vaccination persists 12 months

In a research paper recently uploaded to the preprint server medRxiv* by Havervall et al. (August 12th, 2021), neutralizing antibody titers towards wild-type SARS-CoV-2 and several variants of concern in individuals having either been vaccinated or infected with mild COVID-19 one year earlier are assessed, finding a reduced neutralization capacity against some strains.

Court throws lifeline to seriously ill baby

A seriously ill baby girl has been given a lifeline by a high court in Britain.

Read more Medical News

› Verified 5 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with FMC Brunswick County from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1720351794
Organization NameFmc Brunswick County
Doing Business AsBio-medical Applications Of North Carolina, Inc.
Address98 Stone Chimney Rd. Se Supply, North Carolina, 28462
Phone Number(910) 754-3280

News Archive

First clinical use of GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface on lower profile delivery system

W. L. Gore & Associates (Gore) today reported the first clinical use in the U.S. of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface on a lower profile delivery system. The GORE VIABAHN Device is designed to percutaneously treat Superficial Femoral Artery (SFA) and iliac peripheral artery disease by relining the native vessel.

Research team urges shake-up in mental health provision to enhance patient care

A new study published in the journal Social Theory & Health has called into question how patients interact and respond to psychiatry when they present to mental health services.

Obtained SARS-CoV-2 immunity, naturally or via vaccination persists 12 months

In a research paper recently uploaded to the preprint server medRxiv* by Havervall et al. (August 12th, 2021), neutralizing antibody titers towards wild-type SARS-CoV-2 and several variants of concern in individuals having either been vaccinated or infected with mild COVID-19 one year earlier are assessed, finding a reduced neutralization capacity against some strains.

Court throws lifeline to seriously ill baby

A seriously ill baby girl has been given a lifeline by a high court in Britain.

Read more Medical News

› Verified 5 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data15

News Archive

First clinical use of GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface on lower profile delivery system

W. L. Gore & Associates (Gore) today reported the first clinical use in the U.S. of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface on a lower profile delivery system. The GORE VIABAHN Device is designed to percutaneously treat Superficial Femoral Artery (SFA) and iliac peripheral artery disease by relining the native vessel.

Research team urges shake-up in mental health provision to enhance patient care

A new study published in the journal Social Theory & Health has called into question how patients interact and respond to psychiatry when they present to mental health services.

Obtained SARS-CoV-2 immunity, naturally or via vaccination persists 12 months

In a research paper recently uploaded to the preprint server medRxiv* by Havervall et al. (August 12th, 2021), neutralizing antibody titers towards wild-type SARS-CoV-2 and several variants of concern in individuals having either been vaccinated or infected with mild COVID-19 one year earlier are assessed, finding a reduced neutralization capacity against some strains.

Court throws lifeline to seriously ill baby

A seriously ill baby girl has been given a lifeline by a high court in Britain.

Read more Medical News

› Verified 5 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center22
    Adult patient months included in Kt/V greater than or equal to 1.2183
    Percentage of adult patients getting regular hemodialysis at the center
    Pediatic patients getting regular hemodialysis at the center1
    Pediatric patient months included in in Kt/V greater than or eqaul to 1.23
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    First clinical use of GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface on lower profile delivery system

    W. L. Gore & Associates (Gore) today reported the first clinical use in the U.S. of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface on a lower profile delivery system. The GORE VIABAHN Device is designed to percutaneously treat Superficial Femoral Artery (SFA) and iliac peripheral artery disease by relining the native vessel.

    Research team urges shake-up in mental health provision to enhance patient care

    A new study published in the journal Social Theory & Health has called into question how patients interact and respond to psychiatry when they present to mental health services.

    Obtained SARS-CoV-2 immunity, naturally or via vaccination persists 12 months

    In a research paper recently uploaded to the preprint server medRxiv* by Havervall et al. (August 12th, 2021), neutralizing antibody titers towards wild-type SARS-CoV-2 and several variants of concern in individuals having either been vaccinated or infected with mild COVID-19 one year earlier are assessed, finding a reduced neutralization capacity against some strains.

    Court throws lifeline to seriously ill baby

    A seriously ill baby girl has been given a lifeline by a high court in Britain.

    Read more Medical News

    › Verified 5 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center2
    Adult patient months included in Kt/V greater than or equal to 1.721
    Percentage of adult patients getting regular peritoneal dialysis at the center
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

    News Archive

    First clinical use of GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface on lower profile delivery system

    W. L. Gore & Associates (Gore) today reported the first clinical use in the U.S. of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface on a lower profile delivery system. The GORE VIABAHN Device is designed to percutaneously treat Superficial Femoral Artery (SFA) and iliac peripheral artery disease by relining the native vessel.

    Research team urges shake-up in mental health provision to enhance patient care

    A new study published in the journal Social Theory & Health has called into question how patients interact and respond to psychiatry when they present to mental health services.

    Obtained SARS-CoV-2 immunity, naturally or via vaccination persists 12 months

    In a research paper recently uploaded to the preprint server medRxiv* by Havervall et al. (August 12th, 2021), neutralizing antibody titers towards wild-type SARS-CoV-2 and several variants of concern in individuals having either been vaccinated or infected with mild COVID-19 one year earlier are assessed, finding a reduced neutralization capacity against some strains.

    Court throws lifeline to seriously ill baby

    A seriously ill baby girl has been given a lifeline by a high court in Britain.

    Read more Medical News

    › Verified 5 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC Brunswick County with elevated calcium levels.

Patients with hypercalcemia24
Hypercalcemia patient months205
Hypercalcemia patients with serumcalcium greater than 10.2 mg
Patients with Serumphosphor24
Patients with Serumphosphor less than 3.5 mg/dL
Patients with Serumphosphor from 3.5 to 4.5 mg/dL
Patients with Serumphosphor from 4.6 to 5.5 mg/dL
Patients with Serumphosphor from 5.6 to 7 mg/dL
Patients with Serumphosphor greater than 7 mg/dL

News Archive

First clinical use of GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface on lower profile delivery system

W. L. Gore & Associates (Gore) today reported the first clinical use in the U.S. of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface on a lower profile delivery system. The GORE VIABAHN Device is designed to percutaneously treat Superficial Femoral Artery (SFA) and iliac peripheral artery disease by relining the native vessel.

Research team urges shake-up in mental health provision to enhance patient care

A new study published in the journal Social Theory & Health has called into question how patients interact and respond to psychiatry when they present to mental health services.

Obtained SARS-CoV-2 immunity, naturally or via vaccination persists 12 months

In a research paper recently uploaded to the preprint server medRxiv* by Havervall et al. (August 12th, 2021), neutralizing antibody titers towards wild-type SARS-CoV-2 and several variants of concern in individuals having either been vaccinated or infected with mild COVID-19 one year earlier are assessed, finding a reduced neutralization capacity against some strains.

Court throws lifeline to seriously ill baby

A seriously ill baby girl has been given a lifeline by a high court in Britain.

Read more Medical News

› Verified 5 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 52
Patient months included in arterial venous fistula and catheter summaries 216
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer

News Archive

First clinical use of GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface on lower profile delivery system

W. L. Gore & Associates (Gore) today reported the first clinical use in the U.S. of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface on a lower profile delivery system. The GORE VIABAHN Device is designed to percutaneously treat Superficial Femoral Artery (SFA) and iliac peripheral artery disease by relining the native vessel.

Research team urges shake-up in mental health provision to enhance patient care

A new study published in the journal Social Theory & Health has called into question how patients interact and respond to psychiatry when they present to mental health services.

Obtained SARS-CoV-2 immunity, naturally or via vaccination persists 12 months

In a research paper recently uploaded to the preprint server medRxiv* by Havervall et al. (August 12th, 2021), neutralizing antibody titers towards wild-type SARS-CoV-2 and several variants of concern in individuals having either been vaccinated or infected with mild COVID-19 one year earlier are assessed, finding a reduced neutralization capacity against some strains.

Court throws lifeline to seriously ill baby

A seriously ill baby girl has been given a lifeline by a high court in Britain.

Read more Medical News

› Verified 5 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary
Hospitalization Rate in facility (Not Available)
Hospitalization Rate: Upper Confidence Limit
Hospitalization Rate: Lower Confidence Limit

News Archive

First clinical use of GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface on lower profile delivery system

W. L. Gore & Associates (Gore) today reported the first clinical use in the U.S. of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface on a lower profile delivery system. The GORE VIABAHN Device is designed to percutaneously treat Superficial Femoral Artery (SFA) and iliac peripheral artery disease by relining the native vessel.

Research team urges shake-up in mental health provision to enhance patient care

A new study published in the journal Social Theory & Health has called into question how patients interact and respond to psychiatry when they present to mental health services.

Obtained SARS-CoV-2 immunity, naturally or via vaccination persists 12 months

In a research paper recently uploaded to the preprint server medRxiv* by Havervall et al. (August 12th, 2021), neutralizing antibody titers towards wild-type SARS-CoV-2 and several variants of concern in individuals having either been vaccinated or infected with mild COVID-19 one year earlier are assessed, finding a reduced neutralization capacity against some strains.

Court throws lifeline to seriously ill baby

A seriously ill baby girl has been given a lifeline by a high court in Britain.

Read more Medical News

› Verified 5 days ago